Joseph Allen, OD, FAAO, Dipl ABO
Show Description +
Joseph Allen, OD, FAAO, Dipl ABO, reviews everything you want to know about novel eye drop OTT166 (OcuTerra Therapeutics), which is in development for the treatment of diabetic retinopathy and diabetic macular edema, including its mechanism of action, pathway to the retina, and promising preliminary research findings.
Posted: 4/05/2023
Keywords:
OTT166•
OcuTerra Therapeutics•
Diabetic macular edema, DME•
Diabetic Retinopathy•
eye dropsJoseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Justin Manning, OD, MPH, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Harbir Sian, OD
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO; and Jessilin Quint, OD, MS, MBA, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Rachael Wruble, OD, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Will To, OD, ABOC
Joseph J. Allen, OD, FAAO, Dipl ABO; and Trevor Fosso, OD, FAAO, FSCS
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Laura M. Periman, MD; and Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Jaclyn Garlich, OD, FAAO; and Joseph J. Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Saleel Jivraj, OD, MBA, FAAO, FCOptom, FBCLA
Darryl Glover, OD, Joseph Allen, OD, FAAO
Jennifer Lyerly, OD, Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Solomon Gould, OD, MBA
Joseph Allen, OD, FAAO, Solomon Gould, OD, MBA
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO; Cecelia Koetting, OD, FAAO, Dipl ABO; Jacqueline Theis, OD, FAAO, FNAP; and Jade Coats, OD
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO, reviews everything you want to know about novel eye drop OTT166 (OcuTerra Therapeutics), which is in development for the treatment of diabetic retinopathy and diabetic macular edema, including its mechanism of action, pathway to the retina, and promising preliminary research findings.
Posted: 4/05/2023
Keywords:
OTT166•
OcuTerra Therapeutics•
Diabetic macular edema, DME•
Diabetic Retinopathy•
eye dropsStanislao Rizzo, MD
Hudson de Carvalho Nakamura, MD
Frederic Aissani, MD
Manish Nagpal, MS, DO, FRCS(UK)
Please log in to leave a comment.